关于GLP-1药物怡诺轻剂量选择的态度与影响因素调查 Survey on Attitudes and Influencing Factors in Yinuoqing Dosage Selection

尊敬的怡诺轻使用者 / Dear Yi Nuo Qing Patient,

我们诚挚地邀请您参与本次关于“怡诺轻”用药体验的学术研究。您的真实体验与感受，对于我们理解患者需求、优化治疗服务至关重要。
We sincerely invite you to participate in this academic research on the experience with "Yi Nuo Qing." Your honest feedback is crucial for us to understand patient needs and optimize treatment services.

本问卷匿名填写，所有信息将被严格保密，数据仅用于整体分析。完成问卷约需7-10分钟。感谢您为医疗进步贡献宝贵的力量！
*This questionnaire is anonymous. All information will be kept strictly confidential and used only for aggregate analysis. It takes about 7-10 minutes to complete. Thank you for contributing to medical progress!*

您目前长期居住或接受治疗的地区是？
Which region do you currently live in or receive treatment in?

华东地区 East China (上海 Shanghai, 江苏 Jiangsu, 浙江 Zhejiang, 安徽 Anhui, 福建 Fujian, 江西 Jiangxi, 山东 Shandong)

华北地区 North China (北京 Beijing, 天津 Tianjin, 河北 Hebei, 山西 Shanxi, 内蒙古 Inner Mongolia)

华南地区 South China (广东 Guangdong, 广西 Guangxi, 海南 Hainan)

华中地区 Central China (河南 Henan, 湖北 Hubei, 湖南 Hunan)

西南地区 Southwest China (重庆 Chongqing, 四川 Sichuan, 贵州 Guizhou, 云南 Yunnan, 西藏 Tibet)

西北地区 Northwest China (陕西 Shaanxi, 甘肃 Gansu, 青海 Qinghai, 宁夏 Ningxia, 新疆 Xinjiang)

东北地区 Northeast China (辽宁 Liaoning, 吉林 Jilin, 黑龙江 Heilongjiang)

请问您对“怡诺轻”1mg和3mg两种规格的使用经历是？
What is your experience with the 1mg and 3mg dosages of "Yi Nuo Qing"?

我只使用过1mg规格，从未使用过3mg。 / I have only used the 1mg dosage, never the 3mg.

我从1mg开始使用，并且已经成功升级到3mg。 / I started with 1mg and have successfully upgraded to 3mg.

我从1mg开始使用，曾尝试升级到3mg但未能坚持。 / I started with 1mg, tried to upgrade to 3mg but could not persist.

我起始就使用3mg规格，未经历过1mg。 / I started directly with the 3mg dosage, without using 1mg first.

您至今仍停留在1mg规格，最主要的原因是什么？（请单选）
What is the PRIMARY reason you have remained on the 1mg dosage? (Please select one)

我认为我目前使用1mg效果已足够，无需升级。 / I believes my current results with 1mg are sufficient and no upgrade is needed.

我对升级到3mg可能带来的副作用感到担忧。 / I am concerned about the potential side effects of upgrading to 3mg.

考虑到3mg的价格更高，我认为性价比不高/经济负担较大。 / *Considering the higher cost of 3mg, I don't think it's cost-effective / it's a financial burden.

其他（请简要说明）： / Other (please briefly specify):

在决定是否升级剂量时，以下因素对您的重要程度如何？
When deciding whether to upgrade your dosage, how important are the following factors?

	非常不重要Not Important at all	不重要Not Important	一般重要Important	重要Critical	非常重要Very Critical
3mg规格的每月自付费用 / Monthly out-of-pocket cost for 3mg
3mg规格的每月自付费用 / Monthly out-of-pocket cost for 3mg
升级后疗效的潜在提升 / Potential improvement in efficacy after upgrading
升级后疗效的潜在提升 / Potential improvement in efficacy after upgrading
升级后副作用的潜在风险 / Potential risk of side effects after upgrading
升级后副作用的潜在风险 / Potential risk of side effects after upgrading
主治医生的明确建议 / Explicit recommendation from my primary doctor
主治医生的明确建议 / Explicit recommendation from my primary doctor

回顾您的经历，促使您最终决定从1mg升级到3mg最关键的因素是？（请单选）
Looking back, what was the MOST critical factor in your decision to upgrade from 1mg to 3mg? (Please select one)

医生的强烈且明确的建议。 / A strong and clear recommendation from my doctor.

1mg的效果出现平台期，我渴望获得更好的疗效。 / The effectiveness of 1mg plateaued, and I desired better results.

我计算后发现，虽然3mg更贵，但其疗效提升带来的价值更高/更划算。 / I calculated that the improved efficacy of 3mg offered better value for the money, despite the higher cost.

看到其他病友升级后效果很好，深受影响。 / I was influenced by seeing other patients get good results after upgrading.

在做出升级决定时，3mg增加的额外费用是否曾是一个重要的顾虑点？
When making the upgrade decision, was the additional cost of 3mg a significant concern for you?

是，这是一个重大的顾虑，我深思熟虑后才决定支付。 / Yes, it was a major concern, and I thought carefully before deciding to pay.

是，但有一些支持（如医保、商保、药企援助）减轻了我的负担。 / Yes, but some support (e.g., insurance, patient assistance) reduced my burden.

否，费用对我来说不是问题。 / No, cost was not an issue for me.

您未能坚持使用3mg的最主要原因是？（请单选）
What was the PRIMARY reason you could not persist with the 3mg dosage? (Please select one)

无法耐受的副作用（如严重的恶心、呕吐、腹泻）。 / Intolerable side effects (e.g., severe nausea, vomiting, diarrhea).

升级后感觉疗效提升不明显，认为不值得。 / The perceived improvement in efficacy was not significant enough to justify it.

经济上无法持续负担3mg的费用。 / I could not sustainably afford the cost of 3mg.

其他个人原因。 / Other personal reasons.

如果未来有更全面的财务支持（例如更优的医保覆盖、患者援助项目），您是否会再次考虑尝试3mg？
If more comprehensive financial support were available in the future (e.g., better insurance coverage, patient assistance programs), would you consider trying 3mg again?

会，只要经济障碍消除，我愿意再试。 / Yes, I would be willing to try again if the financial barrier were removed.

不会，主要是因为副作用/疗效原因，与经济无关。 / No, my reason is primarily related to side effects/efficacy, not cost.

不确定。 / Not sure.

您医生建议您起始就使用3mg规格，最主要的原因可能是？（请单选）
What was the likely PRIMARY reason your doctor recommended starting directly with the 3mg dosage? (Please select one)

我的初始病情/体重情况较为严重，需要更强效的治疗。 / My initial condition/weight was more severe, requiring stronger treatment.

我的医生倾向于更积极的治疗方案。 / My doctor prefers a more aggressive treatment approach.

这是我所在地区或医院的常规治疗路径。 / This is the standard treatment pathway in my region/hospital.

10.

对您而言，起始就使用更高剂量的3mg，相关的费用是否是一个容易接受的选择？
For you, was the cost associated with starting directly on the higher 3mg dosage an easily acceptable choice?

是，我完全了解并接受其费用，认为物有所值。 / Yes, I was fully aware and accepted the cost, believing it offered good value.

费用偏高，但基于医生的强烈建议和对疗效的期望，我决定接受。 / The cost was high, but I accepted it based on my doctor's strong recommendation and expectation of efficacy.

费用是一个挑战，但通过保险/援助计划得以解决。 / Cost was a challenge, but it was resolved through insurance/assistance programs.

否，费用负担很重，但我当时没有更好的选择。 / No, the cost is a significant burden, but I felt I had no better option at the time.

问卷星提供技术支持